Top Markets
Coin of the day
Kiromic BioPharma, Inc. Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc.

KRBP
Kedudukan dalam Saham #35637
Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial... Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells. Its developmental pipeline includes ALEXIS-ISO-1, an allogeneic gamma delta CAR-T cell therapy targeting Isomesothelin, and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy designed to address PD-L1. Supporting its research and development efforts, the company holds licensing agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, maintains a collaborative partnership for R&D with Molipharma, S.R.L., and has established a strategic alliance with Leon Office (H.K.) Ltd. Founded in 2006, the entity was initially known as Kiromic, Inc. before officially changing its name to Kiromic BioPharma, Inc. in December 2019. Its operations are headquartered in Houston, Texas.
Harga Saham
$0.11
Disegerakkan terakhir: 2025-05-07
Modal Pasaran
$3.62M
Perubahan (1 hari)
78.86%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Kiromic BioPharma, Inc. (KRBP)

Kategori

EPS untuk Kiromic BioPharma, Inc. (KRBP)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Kiromic BioPharma, Inc., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Kiromic BioPharma, Inc. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE